AXA Stock: Technical Rebound and New Favorable Recommendation from RBC Capital
AXA's stock is up 1.64% this Tuesday morning at 38.35 euros, following several sessions of decline. This rebound occurs as RBC Capital has just issued a positive recommendation on the stock, just days before the announcement of the 2025 annual results scheduled for February 26.
On February 17, Canadian bank RBC Capital initiated coverage of AXA stock with an 'outperform' rating and a target price set at 48.00 euros, compared to the current price of 38.35 euros. This new coverage comes at a pivotal moment for AXA Group, which is set to unveil its 2025 annual accounts on February 26. The general assembly is scheduled for April 30, 2026. The coming weeks are expected to be rich in potential catalysts for the stock of the French insurer.
AXA Stock Still Below Key Moving Averages
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Despite the rise recorded this Tuesday, AXA stock continues to trade below its main moving averages. The 50-day moving average is at 39.44 euros, and the 200-day moving average is at 40.29 euros, indicating a medium-term downward trend, with the current price approximately 5% below this latter benchmark. The decline of 3.01% over the past seven days illustrates this recent selling pressure. The RSI, an indicator measuring the ratio between bullish and bearish movements over 14 sessions, is positioned at 48, which is in a neutral zone, with no oversold or overbought signals. The most relevant support is at 37.46 euros, a level tested during the recent weakness episode from which the stock appears to be rebounding this Tuesday. The annual performance remains modest at 2.19%, while the three-month change is almost nil at -0.36%. The monthly volatility, measured at 5.94, remains contained, consistent with a beta of 0.23, indicating limited sensitivity to general market fluctuations.
we expect underlying earnings of circa. Euro 8.6 billion with underlying EPS growth at the top end of the target range
Risks mentioned
Softening market conditions in large commercial P&C
Natural catastrophe exposure with normalized Nat Cat load of 4.5 points of combined ratio
Interest rate sensitivity with -50bp interest rates shock expected to result in -1pt impact in Solvency II ratio
Opportunities identified
Growth in Life & Savings segment driven by ageing populations and pressure on existing systems
Expansion in direct distribution channel with rising demand for affordable insurance and digital experiences
Deployment of AI across value chain with expected annual recurring benefits of €500-700m (pre-tax) by 2029
Outlook / guidance
Expected EBITDA: 500 millions d'euros
Expected net income: 8 600 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
